¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"outer pillar cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
mulberry cell
¿Àµð¼¼Æ÷
multinuclear giant cell
´ÙÇÙ°Å´ë¼¼Æ÷, ¹µÇÙ°Å´ë¼¼Æ÷
multipolar nerve cell
´Ù±Ø½Å°æ¼¼Æ÷, ¹µ±Ø½Å°æ¼¼Æ÷
myeloid cell
°ñ¼ö¼¼Æ÷
myeloma cell
°ñ¼öÁ¾¼¼Æ÷
myoepithelial cell
±Ù(À°)»óÇǼ¼Æ÷
myoid cell
±Ù(À°)À¯»ç¼¼Æ÷
mantle cell lymphoma
¿ÜÅõ¼¼Æ÷¸²ÇÁÁ¾
marrow cell
°ñ¼ö¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mast cell degranulation
ºñ¸¸¼¼Æ÷Å»°ú¸³
mast cell disease
ºñ¸¸¼¼Æ÷º´
mastoid air cell
²ÀÁö¹úÁý, À¯µ¹¹úÁý
matrix cell
¹ÙÅÁÁú¼¼Æ÷, ±âÁú¼¼Æ÷
memory B cell
±â¾ïB¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
pluripotential cell
´Ù´É¼º¼¼Æ÷
polyhedral cell
¹µ¸éü¼¼Æ÷
polynucleated cell
¹µÇÙ¼¼Æ÷
prickle cell
°¡½Ã¼¼Æ÷
primed cell
ÃÊȸ°¨ÀÛ¼¼Æ÷
primordial germ cell
¿ø½ÃÁ¾ÀÚ¼¼Æ÷
principal cell
ÁÖ¼¼Æ÷
Purkinje cell
½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, Á¶·Õ¹Ú¼¼Æ÷
pyramidal cell
ÇǶó¹Ô¼¼Æ÷
receptor cell
¼ö¿ëü¼¼Æ÷
red blood cell
ÀûÇ÷±¸
reserve cell
¿¹ºñ¼¼Æ÷
residential cell
Á¤ÁÖ¼¼Æ÷
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
reticular cell
±×¹°¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T-cell lymphotrophic virus
Àΰ£ T¼¼Æ÷ ¸²ÇÁ ¿µ¾ç¼º ¹ÙÀÌ·¯½º
human t-cell leukemia virus
ÀÎü T¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
hybrid cell
ÇÏÀ̺긮µå¼¼Æ÷
hybridoma, B cell
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hybridoma, T cell
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hypercomplex cell
Ãʺ¹ÇÕ¼¼Æ÷(õ±ÜÜùêá¬øà)
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
hypersensitivity reactions,type iv(cell-mediated)
IVÇü
hypersensitivity, cell-mediated
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
hypersensitized cell
°ú°¨ÀÛ¼¼Æ÷.
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
hypoxic cell
Àú»ê¼Ò¼¼Æ÷
hypoxic cell sensitizer
Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
i-cell disease
I-¼¼Æ÷º´
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
cell mediated immunity deficiency syndrome
¼¼Æ÷(¸Å°³)¸é¿ª°áÇÌÁõÈıº.
cell mediated immunity deficiency syndrome
¼¼Æ÷¼º¸é¿ª°áÇÌÁõÈıº.
cell mediated lympholysis
¼¼Æ÷¸Å°³ ¸²ÇÁ±¸¿ëÇØ
cell mediated reaction
¼¼Æ÷¸Å°³¼º ¹ÝÀÀ
cell mediated reaction
¼¼Æ÷¸Å°³¼º ¹ÝÀÀ.
cell membrane
¼¼Æ÷¸·
cell membrane
¼¼Æ÷¸·(á¬øàØ¯)
cell membrane
¼¼Æ÷¸·
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º(á¬øàØ¯÷âΦàõ).
cell migration disorder
cell of parathyroid gland
ºÎ°©»ó»ù¼¼Æ÷
cell of reticulum
¹úÁýÀ§Ä
cell organelles
¼¼Æ÷¼Ò±â°ü
cell permeability
¼¼Æ÷Åõ°ú¼º
cell physiology
¼¼Æ÷»ý¸®ÇÐ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½